Markets
BSE See NSE See 61,384.07
-331.98 (-0.54%)

Sun Pharma entered into an agreement with AstraZeneca

Pritam Bhawar / Article rating: 4.5

Sun Pharmaceutical Industries (Sun Pharma) announced that it has entered into a licensing agreement with AstraZeneca UK Ltd. (AstraZeneca) to introduce certain new ready to-use (RTU) infusion oncology products in China. These products will help in cancer treatments. The agreement will play a big role in bringing cost-effective and quality drugs to patients in China.

1345678910Last

Get A Call From Industry Experts

Send Otp

   I authorize DSIJ Pvt Ltd to contact me. This will override registry on the NDNC.

DSIJ MINDSHARE

1345Last

Knowledge

1345Last